GLP-1 Medicines Like Ozempic and Mounjaro: What They Do for Diabetes in Pakistan
A clear look at how GLP-1 injectable medicines work for Type 2 diabetes, their real side effects, and what they actually cost in Pakistan.
Over the last couple of years, names like Ozempic and Mounjaro have moved from doctors' prescription pads into everyday conversation—often talked about as weight-loss injections. But both medicines were developed first, and are still primarily used, for Type 2 diabetes.
If your doctor has mentioned adding a GLP-1 medicine to your treatment, or you're wondering whether it's worth asking about, here is what these medicines actually do, how safe they are, and what they cost in Pakistan today.
What Is a GLP-1 Medicine?
GLP-1 receptor agonists are injectable medicines that copy a natural gut hormone called glucagon-like peptide-1. According to the Cleveland Clinic (opens in a new tab), this hormone (and the medicines that mimic it) does four things in your body at once.
- 1Triggers your pancreas to release insulin when your blood sugar rises after a meal.
- 2Blocks glucagon, the hormone that tells your liver to dump extra sugar into your blood when it isn't needed.
- 3Slows down how quickly food leaves your stomach, which flattens the glucose spike after eating.
- 4Increases how full you feel, which is why appetite and portion sizes often drop noticeably.
Common brand names in this class include semaglutide (Ozempic for diabetes, Wegovy for weight management) and tirzepatide (Mounjaro for diabetes, Zepbound for weight management). Both are given as a once-weekly injection under the skin, similar to how insulin pens are used.
Diabetes Treatment vs. Weight-Loss Marketing
The FDA (opens in a new tab) notes that Ozempic and Mounjaro are approved specifically to improve blood sugar in Type 2 diabetes, while their higher-dose versions, Wegovy and Zepbound, are the ones formally approved for chronic weight management. Weight loss is a real and expected side effect of the diabetes versions too, but the diabetes doses and the weight-management doses are not identical.
This matters in Pakistan, where the same drug is sometimes marketed loosely as a "slimming injection" at aesthetic clinics without the blood sugar monitoring or dose titration that a diabetes specialist would normally build in.
Where GLP-1 Medicines Fit in Your Treatment
The American Diabetes Association's Standards of Care (opens in a new tab) frames GLP-1 receptor agonists as an add-on option alongside Metformin, particularly for people who also carry extra weight, have heart disease, or have kidney disease, since the class has additional benefits beyond blood sugar control.
- Usually added to, not instead of, existing tablets like Metformin—your doctor combines classes that work on different organs.
- Started at a low weekly dose and increased gradually over several weeks to reduce stomach side effects.
- Considered for people whose blood sugar remains above target on tablets alone, or who would also benefit from meaningful weight loss.
Common Side Effects and Safety Warnings
GLP-1 medicines slow digestion, so the most common side effects are digestive: nausea, vomiting, diarrhea, and a reduced appetite, especially when starting or stepping up the dose.
The Cleveland Clinic lists rare but serious risks including pancreatitis (severe abdominal pain), gallbladder problems, and worsening diabetic retinopathy. These medicines are also not used during pregnancy. Report severe or persistent abdominal pain, vomiting that won't stop, or vision changes to your doctor right away rather than waiting it out.
GLP-1 medicines alone rarely cause low blood sugar, but the risk rises when they're combined with insulin or a sulfonylurea like Glimepiride—your doctor may lower those doses when starting a GLP-1 medicine.
Price and Availability in Pakistan
GLP-1 medicines are still out of reach for most households in Pakistan. Branded Ozempic pens cost roughly PKR 22,700–27,750 each, while branded Mounjaro pens run around PKR 195,000, according to Media Bites (opens in a new tab) reporting on the local market.
| Medicine | Molecule | Typical Use in Pakistan | Approx. Local Price |
|---|---|---|---|
| Ozempic | Semaglutide | Type 2 diabetes | PKR 22,700–27,750 per pen |
| Mounjaro | Tirzepatide | Type 2 diabetes | ~PKR 195,000 per pen |
| Local generic injectables | Semaglutide / Tirzepatide | Type 2 diabetes | Lower than imported originals |
Because of that cost gap, several Pakistani manufacturers—including Getz Pharma, Ferozsons, BF Biosciences, and GD Searle—have started producing generic semaglutide and tirzepatide injectables domestically at notably lower prices than the imported originals, though availability and pricing can vary between cities and pharmacies.
“A GLP-1 medicine is a powerful add-on for the right person—but it works alongside your existing treatment plan, not as a replacement for it.”
If your doctor starts you on a GLP-1 medicine, log your blood sugar and any side effects in Diatic so you and your doctor can see the real pattern at your next visit.
Frequently asked questions
Is Ozempic the same as insulin?
No. Ozempic (semaglutide) helps your own pancreas release insulin only when your blood sugar rises after eating, while insulin injections supply the hormone directly. They work differently and are sometimes prescribed together.
Can GLP-1 medicines replace Metformin?
Usually not on their own. Doctors typically add a GLP-1 medicine to existing treatment like Metformin rather than stopping it, since the two classes work on different organs and complement each other.
Why do GLP-1 injections cause nausea when starting?
Because these medicines slow down stomach emptying, food sits longer before moving on, which can cause nausea. Doctors start at a low dose and increase it gradually over several weeks specifically to reduce this.
Are GLP-1 medicines covered or affordable for most patients in Pakistan?
Branded versions like Ozempic and Mounjaro remain expensive for most households, though locally manufactured generic versions have begun appearing at lower prices. Ask your doctor and pharmacist about current local options and costs.
Sources
- American Diabetes Association (ADA) (opens in a new tab)
- Drug Regulatory Authority of Pakistan (DRAP) (opens in a new tab)
- Baqai Institute of Diabetology and Endocrinology (BIDE) (opens in a new tab)
- National Health Service (NHS UK) (opens in a new tab)
- Cleveland Clinic (opens in a new tab)
- U.S. Food and Drug Administration (FDA) (opens in a new tab)
- Media Bites (Pakistan business & health news) (opens in a new tab)
Related reading
Common Diabetes Medicines in Pakistan: Oral Tablets vs. Injected Insulin
A guide to understanding the different classes of diabetes tablets available in Pakistani pharmacies, how they differ, and where insulin fits in.
Metformin Explained Simply: How It Works, Side Effects, and Timing
A straightforward guide to the world's most common diabetes medicine—how it reduces liver sugar release, manages stomach side effects, and when to take it.
Why Insulin and Certain Diabetes Medicines Cause Low Blood Sugar
Understand the physiological triggers behind hypoglycemia—why insulin and sulfonylureas lower sugar, and how to stay safe without fear.
Can You Ever Stop Taking Diabetes Medicine or Insulin?
When and how physicians safely reduce or discontinue medications as glycemic control improves—and why stopping abruptly on your own is dangerous.